-transparent.png){kind=logo}
Opiate receptors play major roles in analgesic and euphoric effects of opiate drugs. Recent cloning of cDNAs encoding the rodent and human mu receptor revealed high homology between the predicted receptors but also some sequence differences. To determine if these sequence differences produced significant changes in ligand-selectivity profiles, we assessed these profiles in expressing COS and CHO cell lines using the agonist ligand [125I]IOXY-AGO (6 beta-[125Iodo]-3,14-dihydroxy-17-methyl-4,5 alpha- epoxymorphinan). This ligand's high specific activity (2,200 Ci/mmol) and high affinity for mu opioid receptors generated high signal-to-noise ratio binding. The resulting ligand-selectivity profiles of the human and rat mu receptors reveal modest differences in affinities for morphine and naloxone in COS cells but not CHO cells. Ligand-selectivity profiles of the rat and human mu receptors were otherwise similar. Interesting differences between these data and data previously obtained with the peptide agonist [3H]DAMGO suggest that the peptide and alkaloid agonists may label different domains of the mu receptor.
R B Rothman, and
H Xu, and
J B Wang, and
J S Partilla, and
H Kayakiri, and
K C Rice, and
G R Uhl
August 1998,
European journal of pharmacology,
R B Rothman, and
H Xu, and
J B Wang, and
J S Partilla, and
H Kayakiri, and
K C Rice, and
G R Uhl
January 2003,
BMC pharmacology,
R B Rothman, and
H Xu, and
J B Wang, and
J S Partilla, and
H Kayakiri, and
K C Rice, and
G R Uhl
August 1998,
Neuroscience,
R B Rothman, and
H Xu, and
J B Wang, and
J S Partilla, and
H Kayakiri, and
K C Rice, and
G R Uhl
September 2000,
The Journal of pharmacology and experimental therapeutics,
R B Rothman, and
H Xu, and
J B Wang, and
J S Partilla, and
H Kayakiri, and
K C Rice, and
G R Uhl
November 1999,
Protein engineering,
R B Rothman, and
H Xu, and
J B Wang, and
J S Partilla, and
H Kayakiri, and
K C Rice, and
G R Uhl
January 1995,
The Journal of pharmacology and experimental therapeutics,
R B Rothman, and
H Xu, and
J B Wang, and
J S Partilla, and
H Kayakiri, and
K C Rice, and
G R Uhl
February 1994,
Molecular pharmacology,
R B Rothman, and
H Xu, and
J B Wang, and
J S Partilla, and
H Kayakiri, and
K C Rice, and
G R Uhl
January 1995,
Journal of neurochemistry,
R B Rothman, and
H Xu, and
J B Wang, and
J S Partilla, and
H Kayakiri, and
K C Rice, and
G R Uhl
November 1997,
Neuroscience,
R B Rothman, and
H Xu, and
J B Wang, and
J S Partilla, and
H Kayakiri, and
K C Rice, and
G R Uhl
October 1995,
European journal of pharmacology,
